Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women

Launched by UNIVERSITY OF COLORADO, DENVER · May 28, 2024

Keywords

ClinConnect Summary

The "Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information" study is looking into why some women might not want to receive personalized information about their risk of breast cancer, especially in relation to mammogram screenings. This research is important because it aims to help improve how we communicate cancer risk to women, enabling them to make better-informed decisions about their health.

To participate in this study, you must be a woman aged between 39 and 49 who can read and understand English. However, if you have had breast cancer before, certain types of non-invasive breast cancer, or specific genetic conditions, you won't be eligible to join. If you take part, you will help researchers learn more about the challenges women face when it comes to understanding their breast cancer risk, which could lead to better support and resources for others in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Female sex
• • 2. Age 39-49 (i.e., people who are eligible for routine breast cancer screening and for whom guidelines recommend an informed, risk-based decision)
• • 3. English literacy
• Exclusion Criteria:
• • 1. Prior diagnosis of
• • 1. breast cancer
• • 2. Ductal carcinoma in situ (DCIS)
• • 3. Lobular carcinoma in situ (LCIS)
• • 4. Known BRCA1/2 gene mutation
• • 5. Cowan syndrome
• • 6. Li-Fraumeni syndrome
• • 7. Having received previous chest radiation for treatment of Hodgkin's lymphoma.

Trial Officials